Nicholas Corcoran - 10 Jul 2026 Form 4 Insider Report for TransMedics Group, Inc. (TMDX)

Reporting relationship: SVP of Supply Chain and Operations
Issuer ticker: TMDX
Reported as of: 10 Jul 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 14 Jul 2026, 21:37:39 UTC
Prior SEC filing: 04 Mar 2026
Source filing: View source filing
Reporting owner signature: By: /s/ Gerardo Hernandez, Attorney-in-Fact

Key filing fact

Nicholas Corcoran filed Form 4 for TransMedics Group, Inc. (TMDX) on 14 Jul 2026.

Key facts

This page summarizes Nicholas Corcoran's Form 4 filing for TransMedics Group, Inc. (TMDX).
2 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 14 Jul 2026, 21:37.

Change

Previous filing in this sequence was filed on 04 Mar 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001964148 Primary reporting owner

Corcoran Nicholas

Relationship: SVP of Supply Chain and Operations
Address: C/O TRANSMEDICS GROUP, INC., 200 MINUTEMAN ROAD, ANDOVER
Signature: By: /s/ Gerardo Hernandez, Attorney-in-Fact
Signature date: 14 Jul 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

TMDX transaction

Common Stock

Award

Transaction value
Shares: +11,727
Change %: +39%
Price: $0.000000^*
Shares after: 41,558
Date: 10 Jul 2026
Ownership: Direct
Footnotes: F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

TMDX transaction Derivative

Stock Option (Right to Buy)

Award

Transaction value
Shares: +17,784
Change %
Price: $0.000000^*
Shares after: 17,784
Date: 10 Jul 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 17,784
Exercise price: $71.23
Footnotes: F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Consists of 11,727 restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock.

Footnote F2

The option vests at a rate of 2.0833% of the total number of shares subject to the option each month following April 10, 2026 until the option is fully vested on April 10, 2030, subject to continued service.

SEC remarks

SVP of Supply Chain and Operations